A study in humans with coronary artery disease demonstrated that the mir-7106-3p is downregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention, as identified by next-generation miRNA sequencing and validated with a false discovery rate correction [Onuoha et al. DOI:10.1111/cts.13307].